New biobank aims to unlock secrets of preterm infant development

NCT ID NCT07490912

Recruiting now Knowledge-focused Sponsor: University Hospital of Cologne Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is creating a large collection of health data and biological samples from very preterm infants (born before 32 weeks or weighing less than 1500 grams). Researchers will follow these children for several years to see how they develop. The goal is to find factors that help or harm their long-term health, which could lead to better care in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could identify early risk and protective factors, leading to better monitoring and targeted interventions for preterm infants.
What could go wrong: This is an observational study, not a treatment trial. It will not directly improve outcomes, and findings may take years to translate into clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREMATURE BIRTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREMATURE BIRTH PREMATURITY COMPLICATIONS PRETERM INFANT DEVELOPMENT PRETERM INFANT HEALTH

Contacts and locations

Locations

University Hospital Cologne
RECRUITING

Cologne, North Rhine-Westphalia, 50937, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.